中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

阿奇霉素联合普米克令舒治疗支原体肺炎的临床效果观察

卢娟毅

(长安区妇幼保健院,陕西 西安,710100)

浏览次数:97次 下载次数:466次

摘要:

目的 研究阿奇霉素联合普米克令舒治疗支原体肺炎的临床效果。方法 本次研究选取的研究对象为2015年1月至2016年1月在我院进行治疗的支原体肺炎患儿,将80例患儿简单随机分为两组,每组40例。两组均进行常规治疗,对照组患儿实施阿奇霉素序贯疗法,观察组在对照组的基础上采用普米克令舒治疗。对比两组支原体肺炎患儿的临床症状消失时间、临 床总有效率、住院时间及不良反应发生率。结果 观察组支原体肺炎患儿的临床症状消失时间、临床总有效率、住院时间及不 良反应发生率与对照组患儿相比更具优势(P<0.05)。结论在支原体肺炎患儿的治疗中应用阿奇霉素联合普米克令舒安全有效,具有较高的临床应用价值。

关键词:支原体肺炎;阿奇霉素;普米克令舒

中图分类号:R725.6文献标志码:A文章编号:2096-1413(2017)06-0109-02

    Clinical effect of azithromycin combined with pulmicort respules in the treatment of mycoplasmal pneumonia
    LU Juan-yi
    (Chang'an Maternal and Child Care Service Centre, Xi'an 710100, China)

    ABSTRACT: Objective To explore the clinical effect of azithromycin combined with pulmicort respules in the treatment of mycoplasmal pneumonia. Methods Eighty children with mycoplasmal pneumonia from January 2015 to January 2016 in our hospital were selected as the research objects and randomly devided into the observation group and control group, with 40 cases in each group. The patients of control group received azithromycin sequential therapy and the observation group was given pulmicort respules based on the treatment of the control group. The clinical symptoms disappear time, total clinical effect, hospital stay time and complication incidence rate of the two groups were compared. Results The clinical symptoms disappear time, total clinical effect, hospital stay time and complication incidence rate of the observation group were better than those of the control group (P<0.05). Conclusion Azithromycin combined with pulmicort respules in the treatment of mycoplasmal pneumonia is safe and effective, which has higher clinical application value.
    KEYWORDS: mycoplasmal pneumonia; azithromycin; pulmicort respules

    参考文献:
    [1] 沈英鹏.阿奇霉素联合普米克令舒治疗支原体肺炎患儿的临床效果研究[J].中国妇幼保健,2014,29(14):2274-2276.
    [2] 杨膺,黄贇,谈钧佩,等.普米克令舒联合阿奇霉素治疗小儿支原体肺炎[J].中国妇幼健康研究,2013,24(1):61-63.
    [3] 楚加元,许洲.阿奇霉素序贯疗法用于儿童支原体肺炎的临床观察[J].中国药房,2016,27(18):2521-2523.
    [4] 鞠亦男.普米克令舒佐治疗小儿支原体肺炎的疗效观察[J].临床医药文献杂志:电子版,2015,2(13):2554.
    [5] LUO Z,LUO J,LIU E,et al.Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children[J].Pediatr Pulmonol,2014,49 (4):377-380.
    [6] 鞠亦男.普米克令舒佐治小儿肺炎支原体肺炎疗效观察[J].健康导报:医学版,2014,19(5):64.
    [7] 王海飞.普米克令舒治疗小儿支原体肺炎的不良反应分析[J].吉林医学,2014,35(3):523.
    [8] 王丽民.雾化吸入普米克令舒佐治肺炎支原体肺炎46例疗效观察[J].中国中西医结合儿科学,2013,5(3):251-252.
    [9] 曹效红.甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性分析[J].国际医药卫生导报,2016,22(12):1745-1748.
    [10] 户波,毋英超.普米克令舒联合阿奇霉素治疗102例儿童肺炎支原体感染的疗效观察[J].中国医学创新,2015,12(4):38-40.

上一篇多巴胺联合西地兰治疗小儿肺炎合并心力衰竭临床疗效

下一篇双黄连注射液治疗肺炎小儿患者的疗效观察